NCT03275727

Brief Summary

Background: Internet-delivered interventions (IDI) can provide remarkable opportunities in addressing breast cancer (BC) survivors' unmet needs, as they present an effective strategy to improve care coordination and provide access to efficacious, cost-efficient and convenient survivorship care. Nevertheless, research focusing on this field and aiming at improving survivors´ psychosocial needs is scarce and its practical implementation is limited. Objectives: This study aims at studying BC patients´ and healthcare providers' attitudes towards IDI; exploring BC patients´ unmet support needs and; determining the acceptability, feasibility, efficacy and cost-effectiveness of iACT-BC, a guided internet-delivered individually-tailored ACT-influenced cognitive behavioural intervention designed to improve psychosocial outcomes in BC survivors when compared to treatment as usual. The primary outcomes in this research are anxiety and depression. Secondary outcomes include psychological flexibility, fatigue, insomnia, Sexual dysfunction (SD) and Health Related Quality of Life. Methods: A multimethod research design will be applied and two consecutive studies will be performed. Study 1 will explore participants´ attitudes towards IDI as well as, BC patients' psychosocial unmet needs by adopting an exploratory cross-sectional study design. Study 2 will investigate the effectiveness and cost-effectiveness of iACT-BC in BC survivors, by implementing a two-arm, parallel, open label, multicentre, waiting list randomized controlled trial. Expected Results: It is anticipated that iACT-BC will show to be an effective and cost-effective program in improving anxiety, depression, psychological flexibility, fatigue, insomnia, SD and HRQoL in BC survivors, as opposing to a waiting list control under treatment as usual. The results of this research will be published in accordance with CONSORT 2010 and CONSORT-EHEALTH guidelines and should be available for publication in February 2020.

Trial Health

35
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
128

participants targeted

Target at P75+ for phase_2

Timeline
Completed

Started Feb 2018

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

September 1, 2017

Completed
7 days until next milestone

First Posted

Study publicly available on registry

September 8, 2017

Completed
5 months until next milestone

Study Start

First participant enrolled

February 1, 2018

Completed
1.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2019

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2019

Completed
Last Updated

September 8, 2017

Status Verified

September 1, 2017

Enrollment Period

1.8 years

First QC Date

September 1, 2017

Last Update Submit

September 7, 2017

Conditions

Keywords

Breast CancerSurvivorsInternet interventionPsychosocial interventionAcceptance and Commitment Therapy (ACT)Randomized controlled trial

Outcome Measures

Primary Outcomes (2)

  • Depression

    Patient Health Questionnaire (PHQ-9)

    Change from baseline to post-intervention (10 weeks after enrollment), Follow-ups at 3, 6 and 12 months

  • Anxiety

    Generalized Anxiety Disorder Scale (GAD-7)

    Change from baseline to post-intervention (10 weeks after enrollment), Follow-ups at 3, 6 and 12 months

Secondary Outcomes (6)

  • Psychological flexibility

    Change from baseline to post-intervention (10 weeks after enrollment), Follow-ups at 3, 6 and 12 months

  • Fatigue

    Change from baseline to post-intervention (10 weeks after enrollment), Follow-ups at 3, 6 and 12 months

  • Insomnia

    Change from baseline to post-intervention (10 weeks after enrollment), Follow-ups at 3, 6 and 12 months

  • Sexual dysfunction

    Change from baseline to post-intervention (10 weeks after enrollment), Follow-ups at 3, 6 and 12 months

  • Health related quality of life - generic measure

    Change from baseline to post-intervention (10 weeks after enrollment), Follow-ups at 3, 6 and 12 months

  • +1 more secondary outcomes

Other Outcomes (4)

  • Participants' attitudes towards internet interventions

    Change from baseline to post-intervention (10 weeks after enrollment), Follow-ups at 3, 6 and 12 months

  • Breast cancer patients' unmet support needs

    Change from baseline to post-intervention (10 weeks after enrollment), Follow-ups at 3, 6 and 12 months

  • Intervention cost-effectiveness

    Change from baseline to post-intervention (10 weeks after enrollment), Follow-ups at 3, 6 and 12 months

  • +1 more other outcomes

Study Arms (2)

A - iACT-BC experimental group

EXPERIMENTAL
Behavioral: iACT-BC

B - Waiting list control group

OTHER
Behavioral: iACT-BC

Interventions

iACT-BCBEHAVIORAL

A Guided INternet-delivered Individually-tailored ACT-influenced Cognitive Behavioural INtervention to ImprOVe Psychosocial Outcomes in Breast Cancer Survivors

A - iACT-BC experimental groupB - Waiting list control group

Eligibility Criteria

Age18 Years+
Sexfemale(Gender-based eligibility)
Gender Eligibility DetailsOnly female BC survivors
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Signed written informed consent.
  • Age ≥ 18 years;
  • Ability to read and write in Portuguese.
  • History of histologically or cytologically confirmed breast cancer with no evidence of metastatic disease.
  • An interval ≥ 6 month from primary adjuvant treatment completion (surgery, chemotherapy and/or radiotherapy), except for hormonal therapy.
  • Clinically significant symptoms of at least one of the following conditions: anxiety, depression, fatigue, insomnia and/or sexual dysfunction.
  • Ongoing regular psychoactive medication only accepted if dosage has been stable during the last 3 months.
  • Daily access to the Internet by computer and/or smartphone.
  • Ability to use a computer and/or smartphone and the internet.
  • No participation on any other interventional study or clinical trial.

You may not qualify if:

  • Age ≤ 18 years;
  • Inability to co-operate and give informed consent.
  • Breast cancer not histologically or cytologically confirmed.
  • History of other malignancy within the last 5 years.
  • Metastasized breast cancer.
  • Current severe, uncontrolled systemic disease or mental disorder.
  • Absence of clinically significant symptoms.
  • Parallel ongoing psychological treatment.
  • Ongoing regular psychoactive medication if dosage has been changed during the last 3 months.
  • No access to the internet.
  • Inability to use a computer and/or smartphone and the internet.
  • Parallel ongoing participation in other interventional study or clinical trial.
  • Assessment by the investigator to be unable or unwilling to comply with the requirements of the protocol.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Related Publications (1)

  • Mendes-Santos C, Weiderpass E, Santana R, Andersson G. A guided internet-delivered individually-tailored ACT-influenced cognitive behavioural intervention to improve psychosocial outcomes in breast cancer survivors (iNNOVBC): Study protocol. Internet Interv. 2019 Feb 10;17:100236. doi: 10.1016/j.invent.2019.01.004. eCollection 2019 Sep.

MeSH Terms

Conditions

Breast Neoplasms

Condition Hierarchy (Ancestors)

Neoplasms by SiteNeoplasmsBreast DiseasesSkin DiseasesSkin and Connective Tissue Diseases

Central Study Contacts

Cristina M Santos, MsC

CONTACT

Gerhard Andersson, PhD

CONTACT

Study Design

Study Type
interventional
Phase
phase 2
Allocation
RANDOMIZED
Masking
NONE
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Sponsor Type
OTHER GOV
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

September 1, 2017

First Posted

September 8, 2017

Study Start

February 1, 2018

Primary Completion

December 1, 2019

Study Completion

December 1, 2019

Last Updated

September 8, 2017

Record last verified: 2017-09

Data Sharing

IPD Sharing
Will not share